Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tripartite motif containing 16-like (TRIM16L), also known as TRIM70, is a human protein belonging to the TRIM (tripartite motif-containing) family, characterized by multiple zinc-finger domains and a coiled-coil structure. While the TRIM family participates in diverse biological processes, there is currently no published evidence establishing the specific molecular function, cellular roles, disease associations, or targeting of TRIM16L. Most functional studies and disease links in the literature concern TRIM16, which possesses well-documented tumor suppressor functions and E3 ubiquitin ligase activity, but these should not be attributed to TRIM16L without direct evidence. Therefore, TRIM16L’s classification as a therapeutic target remains unsubstantiated, and attempts to identify pharmacology, biomarkers, or disease relevance must be considered unreliable at present. In summary, TRIM16L is a poorly characterized TRIM family protein, often conflated with TRIM16. There is currently insufficient or incorrect information to support its status as a defined therapeutic target, molecular function, or disease role.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tripartite motif containing 16-like (TRIM16L).